Fresenius Medical Care: Initiation Of Coverage - Innovation with AR in Dialysis Training & 4 Other Major Drivers
Fresenius Medical Care's Q4 2023 earnings highlighted the progress made against their strategic plan that was set out a year prior. The plan...
GLP-1 Drugs – Are They Dessert or Time Bomb to Your Portfolio?
GLP-1s will be the next major opportunity in healthcare, which won't be limited to weight loss drugs. But when they expand new indications,...
Tweedy, Browne Fund Q3 2022 Commentary
Tweedy, Browne Company LLC provides investment advisory services. The Company offers portfolio management, financial planning, and consulting...
No more insights